Follow-up study of left heart valve regurgitation after implantation of left ventricular assist device
10.12025/j.issn.1008-6358.2025.20240938
- VernacularTitle:心室辅助装置植入后左心瓣膜反流的随访研究
- Author:
Junjiang LIU
1
;
Wenrui MA
1
;
Dingqian LIU
1
;
Yun ZHAO
1
;
Lili DONG
2
;
Zhe LUO
3
;
Kefang GUO
4
;
Chunsheng WANG
1
;
Xiaoning SUN
1
Author Information
1. Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
2. Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
3. Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
4. Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Publication Type:Originalarticle
- Keywords:
left ventricular assist device;
heart failure;
left heart valve regurgitation;
prognosis
- From:
Chinese Journal of Clinical Medicine
2025;32(1):72-77
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the valve regurgitation status of left heart after the implantation of left ventricular assist device (LVAD) and its effect on prognosis of patients with LVAD implantation. Methods A total of 35 patients with cardiomyopathy who underwent magnetic levitation LVAD implantation at Zhongshan Hospital, Fudan University from February 2021 to July 2024 were retrospectively selected. Clinical data during hospitalization were collected, including preoperative basic data and postoperative valve regurgitation status. Telephone follow-ups were conducted to monitor patients’ survival status and transthoracic echocardiography was used to assess left valve function. Kaplan-Meier survival curves and log-rank test were employed to compare the survival rate of patients with different levels of valve regurgitation. Results The 35 patients had a mean age of (53.9±11.1) years, with 85.7% male, and 3 patients (8.6%) died during hospitalization. Preoperatively, 17 patients (48.6%) had moderate or greater mitral regurgitation, while all 35 patients had less than moderate aortic regurgitation. One month postoperatively, thirty patients were followed up, among which 24 patients (80%) had less than moderate mitral regurgitation, including 11 cases with alleviated regurgitation compared to pre-surgery; 6 patients (20%) had moderate or greater mitral regurgitation, including 4 cases with stable regurgitation and 2 cases with progression of regurgitation compared to pre-surgery; 2 patients (6.7%) had progression of aortic regurgitation to moderate or greater. The follow-up time was 1.2 (1.0, 2.1) years, with 1-year survival rate of 91.4% and 3-year survival rate of 71.1%. Survival analysis showed that the 3-year survival rate of patients with moderate or greater mitral regurgitation one month postoperatively was significantly lower than that of patients with less than moderate regurgitation (66.7% vs 83.3%, P＝0.046). Conclusions After the implantation of magnetic levitation LVAD, most patients showed improvement in mitral regurgitation, while aortic regurgitation remained unchanged. The degree of mitral regurgitation one month postoperatively is associated with prognosis.
